Ignite Creation Date:
2024-05-06 @ 1:18 PM
Last Modification Date:
2024-10-26 @ 1:12 PM
Study NCT ID:
NCT03989713
Status:
TERMINATED
Last Update Posted:
2022-09-15
First Post:
2019-04-12
Brief Title:
Quizartinib and High-dose Ara-C Plus Mitoxantrone in RelapsedRefractory AML With FLT3-ITD
Sponsor:
Prof Dr Richard F Schlenk
Organization:
University Hospital Heidelberg
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-17
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-11
Completion Date Type:
ACTUAL
First Submit Date:
2019-04-12
First Submit QC Date:
June 14 2019
Study First Post Date:
2019-06-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-12
Last Update Post Date:
2022-09-15
Last Update Post Date Type:
ACTUAL